Blog - SeraNovo B.V.

SeraNovo acquires MIT Feasibility subsidy

Alternative Text   Bastiaan Kluft
 June 5, 2017

Using the services of their grant writer, Dr. Coos van Laar from BioTop, SeraNovo have successfully applied and received the MIT Feasibility grant from RVO worth €25.000,-!

Good Biomarker Sciences Collaboration

Alternative Text   Bastiaan Kluft
 May 1, 2017

SeraNovo have signed a collaboration agreement with Good Biomarker Sciences B.V. (GBS) detailing the increased collaboration between these two parties.

Enterprise Leiden Fund Loan

Alternative Text   Niall Hodgins
 February 15, 2017

SeraNovo has acquired a €30,000 loan from the Enterprise Leiden Fund to develop our drug formulation platform.

Bastiaan Kluft joins SeraNovo as partner

Alternative Text   Niall Hodgins
 September 1, 2016

Bastiaan Kluft, who has a background in Chemistry & Science Based Business, is joining SeraNovo as of the start of September 2016

SeraNovo wins Gulliver prize for Best Student Entrepreneur 2016

Alternative Text   Niall Hodgins
 June 15, 2016

SeraNovo won the prestigious Gulliver prize amongst fierce competition between startups. The student entrepreneur competition, set up by Science meets Business and Lugus